Websitehttps://india-pharma.gsk.com/en-in/ Peer analysis Key Information CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per...
10 Oct 2023 GlaxoSmithKline terminates the phase III contRAst X trial in Rheumatoid arthritis in United Kingdom, Ukraine, Thailand, Spain, South Africa, Serbia, Russia, Poland, Mexico, Mexico, Czech Republic, Malaysia, Lithuania, Latvia, South Korea, India, Japan, Hungary, Germany, Estonia, Colo...
A key focus for the regional pharma supply team is on reducing costs so that GlaxoSmithKline can compete more effectively in all its markets. There are 31 sites in 23 countries in Regional pharma supply. New product and global supply New product and global supply focuses on ensuring that the ...
the group operating margin, earnings per share, and cash flow. Group sales growth of 5% in CER terms reflected an increase in sales in all three of our global businesses, with a particularly strong performance in vaccines. The Pharma business continues to shift its portfolio shape with ...